Temporal and spatial control over soluble protein signaling for musculoskeletal tissue engineering

Proceedings of the 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society: Engineering the Future of Biomedicine, EMBC 2009

Volumn , Issue , 2009, Pages 2103-2105

  Murphy, William L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL EQUIPMENT; MUSCULOSKELETAL SYSTEM; SIGNALING; STEM CELLS; TISSUE; TISSUE ENGINEERING;

CLINICAL METHODS; COMPLEX PROCESSES; CYTOKINE SIGNALING; NATURAL TISSUES; ORTHOPEDIC TISSUE ENGINEERING; SOLUBLE PROTEINS; TEMPORAL AND SPATIAL; TISSUE INTERFACE;

TISSUE REGENERATION;

EID: 77951007602     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2009.5334306     Document Type: Conference Paper

References (33)

1. G. M. Crane, S. L. Ishaug, and A. G. Mikos, "Bone tissue engineering," Nat Med, vol.1, pp. 1322-1324, 1995.
2. K. Enterprises, "The Worldwide Orthopaedic Market," The Institute for Orthopaedic Enlightenment, Chagrin Falls, OH 2003.
3. N. C. f. H. Statistics, Ambulatory and inpatient procedures according to place, sex, age, and type of procedure: United States, 1994-1998. Hyattsville, MD: U.S. Department of Health and Human Services, 2000.
4. M. Insight, "Trends and Opportunities in U.S. Orthopedic Markets for Implant, Reconstruction, and Trauma Products," Medtech Insight, Newport Beach, CA March 2004 2004.
5. R. M. Linn, D. A. Fischer, J. P. Smith, D. B. Burstein, and D. C. Quick, "Achilles tendon allograft reconstruction of the anterior cruciate ligament-deficient knee," Am J Sports Med, vol.21, pp. 825-831, 1993.
6. J. U. Buelow, R. Siebold, and A. Ellermann, "A new bicortical tibial fixation technique in anterior cruciate ligament reconstruction with quadruple hamstring graft," Knee Surg Sports Traumatol Arthrosc, vol.8, pp. 218-225, 2000.
7. W. L. G. Murphy, K.; Vanderby, R., "Healing of Bone and Connective Tissues," in Encyclopedia of Biomaterials and Biomedical Engineering, G. B. Wnek, G., Ed.: Informa Healthcare, 2006.
8. T. Kohno, Y. Ishibashi, E. Tsuda, T. Kusumi, M. Tanaka, and S. Toh, "Immunohistochemical demonstration of growth factors at the tendon-bone interface in anterior cruciate ligament reconstruction using a rabbit model," J Orthop Sci, vol.12, pp. 67-73, 2007.
9. S. A. Rodeo, K. Suzuki, X. H. Deng, J. Wozney, and R. F. Warren, "Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel," Am J Sports Med, vol.27, pp. 476-488, 1999.
10. T. Yoshikawa, H. Tohyama, T. Katsura, E. Kondo, Y. Kotani, H. Matsumoto, Y. Toyama, and K. Yasuda, "Effects of local administration of vascular endothelial growth factor on mechanical characteristics of the semitendinosus tendon graft after anterior cruciate ligament reconstruction in sheep," Am J Sports Med, vol.34, pp. 1918-1925, 2006.
11. Y. Kimura, A. Hokugo, T. Takamoto, Y. Tabata, and H. Kurosawa, "Regeneration of anterior cruciate ligament by biodegradable scaffold combined with local controlled release of basic fibroblast growth factor and collagen wrapping," Tissue Eng Part C Methods, vol.14, pp. 47-57, 2008.
12. B. Demirag, B. Sarisozen, O. Ozer, T. Kaplan, and C. Ozturk, "Enhancement of tendon-bone healing of anterior cruciate ligament grafts by blockage of matrix metalloproteinases," J Bone Joint Surg Am, vol.87, pp. 2401-2410, 2005.
13. W. M. Saltzman and W. L. Olbricht, "Building drug delivery into tissue engineering," Nat Rev Drug Discov, vol.1, pp. 177-186, 2002.
14. S. Cohen, T. Yoshioka, M. Lucarelli, L. H. Hwang, and R. Langer, "Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres," Pharm Res, vol.8, pp. 713-720, 1991.
15. R. Langer, "New methods of drug delivery," Science, vol.249, pp. 1527-1533, 1990.
16. R. Langer and J. Folkman, "Polymers for the sustained release of proteins and other macromolecules," Nature, vol.263, pp. 797-800, 1976.
17. R. Langer and M. Moses, "Biocompatible controlled release polymers for delivery of polypeptides and growth factors," J Cell Biochem, vol.45, pp. 340-345, 1991.
18. K. W. Leong, J. Kost, E. Mathiowitz, and R. Langer, "Polyanhydrides for controlled release of bioactive agents," Biomaterials, vol.7, pp. 364-371, 1986.
19. K. J. Pekarek, J. S. Jacob, and E. Mathiowitz, "Double-walled polymer microspheres for controlled drug release," Nature, vol.367, pp. 258-260, 1994.
20. K. Y. Lee, M. C. Peters, K. W. Anderson, and D. J. Mooney, "Controlled growth factor release from synthetic extracellular matrices," Nature, vol.408, pp. 998-1000, 2000.
21. Y. Tabata and Y. Ikada, "Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities," Biomaterials, vol.20, pp. 2169-2175, 1999.
22. F. a. Sullivan, U.S. Drug Delivery Technology Markets: Frost and Sullivan, 2001.
23. W. L. Murphy, M. C. Peters, D. H. Kohn, and D. J. Mooney, "Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering," Biomaterials, vol.21, pp. 2521-2527, 2000.
24. W. L. Murphy, C. A. Simmons, D. Kaigler, and D. J. Mooney, "Bone regeneration via a mineral substrate and induced angiogenesis," J Dent Res, vol.83, pp. 204-210, 2004.
25. M. H. Sheridan, L. D. Shea, M. C. Peters, and D. J. Mooney, "Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery," J Control Release, vol.64, pp. 91-102., 2000.
26. S. M. W. Howdle, M.S.; Whitaker, M.J.; Popov, M.C.; Davies, M.C.; Mandel, F.S.; Wang, J.D.; Shakesheff, K.M., "Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials," Chemical Communications, vol.1, 2001.
27. X. B. Yang, D. W. Green, H. I. Roach, N. M. Clarke, H. C. Anderson, S. M. Howdle, K. M. Shakesheff, and R. O. Oreffo, "Novel osteoinductive biomimetic scaffolds stimulate human osteoprogenitor activity - implications for skeletal repair," Connect Tissue Res, vol.44 Suppl 1, pp. 312-317, 2003.
28. T. P. Richardson, M. C. Peters, A. B. Ennett, and D. J. Mooney, "Polymeric system for dual growth factor delivery," Nat Biotechnol, vol.19, pp. 1029-1034, 2001.
29. A. H. Zisch, U. Schenk, J. C. Schense, S. E. Sakiyama-Elbert, and J. A. Hubbell, "Covalently conjugated VEGF - fibrin matrices for endothelialization," J Control Release, vol.72, pp. 101-113, 2001.
30. A. T. Raiche and D. A. Puleo, "Cell responses to BMP-2 and IGF-I released with different time-dependent profiles," J Biomed Mater Res, vol.69A, pp. 342-350, 2004.
31. A. T. Raiche and D. A. Puleo, "In vitro effects of combined and sequential delivery of two bone growth factors," Biomaterials, vol.25, pp. 677-685, 2004.
32. L. Jongpaiboonkit, T. Franklin-Ford, and W. L. Murphy, "Mineralcoated, biodegradable microspheres for controlled protein binding and release," Advanced Materials, vol.In Press, 2009.
33. B. J. Peret and W. L. Murphy, "Controllable soluble protein concentration gradients in hydrogel networks," Advanced Functional Materials, vol.18, pp. 3410-3417, 2008.